Multiomics Market worth $5.70 billion by 2031
The report "Multiomics Market by Offerings [Product (Instrument, Kits, Reagents), Service], Method (Epigenomics, Single Cell, Spatial), Technology [Sequencing, Proteomics (NGS, PCR, MS)], Workflow (Sample Prep), Application, Competition - Global Forecast to 2031", The global multiomics market is projected to reach USD 5.70 billion by 2031 from USD 3.18 billion in 2026, at a CAGR of 12.3% during the forecast period. The global Multiomics market is experiencing growth, driven by increasing accessibility of high-quality, integrated omics data for research.
Browse 976 market data Tables and 476 Figures spread through 245 Pages and in-depth TOC on "Multiomics Market by Offerings [Product (Instrument, Kits, Reagents), Service], Method (Epigenomics, Single Cell, Spatial), Technology [Sequencing, Proteomics (NGS, PCR, MS)], Workflow (Sample Prep), Application, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/multiomics-market-213195527.html
The sequencing & analysis/sample characterization segment accounted for the largest share of the global multiomics market, by workflow, in 2025.
Based on workflow, the multiomics market is segmented into sample preparation, sequencing & analysis/sample characterization, and data visualization & analysis. The sequencing & analysis/sample characterization segment dominated the market in 2025, driven by the widespread adoption of next-generation sequencing (NGS), high-resolution mass spectrometry, single-cell sequencing, and spatial omics technologies for comprehensive molecular profiling. Increasing demand for integrated genomic, transcriptomic, proteomic, metabolomic, and epigenomic analyses in biomarker discovery, precision medicine, drug development, and translational research continues to support segment growth. Additionally, continuous advancements in sequencing platforms, mass spectrometry systems, and high-throughput analytical technologies have improved data quality, throughput, and scalability, reinforcing the segment's leading position in the global multiomics market.
Sequencing technologies are estimated to be the fastest-growing type segment in the multiomics market.
Based on technology, the multiomics market is segmented into sequencing, proteomics technologies, and other technologies. The sequencing technologies segment dominated the market in 2025 due to the widespread adoption of next-generation sequencing (NGS) for integrated genomic, transcriptomic, epigenomic, and single-cell analyses. Continuous advancements in sequencing accuracy, throughput, and cost efficiency, coupled with increasing applications in biomarker discovery, precision medicine, population genomics, and translational research, have accelerated technology adoption. Furthermore, the growing use of long-read sequencing, spatial transcriptomics, and multiomic sequencing platforms capable of simultaneously analyzing multiple molecular layers has reinforced the segment's leading position in the global multiomics market.
North America accounted for the largest regional share in the global multiomics market in 2025.
The multiomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America accounted for the largest share of the global multiomics market, driven by the presence of a well-established biotechnology and pharmaceutical ecosystem, strong investments in genomics and precision medicine research, and early adoption of advanced multiomics technologies. The region benefits from significant government and institutional funding for life sciences research, extensive adoption of next-generation sequencing (NGS), single-cell omics, and spatial omics platforms, and a strong presence of leading technology providers and academic research institutions. Additionally, increasing applications of multiomics in oncology, biomarker discovery, drug discovery and development, and personalized medicine continue to support the region’s dominant market position.
Key players operating in the North American multiomics market include 10x Genomics, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bruker Corporation (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), QIAGEN N.V. (Netherlands), and Bio-Rad Laboratories, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Multiomics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
